Health Education During Ramadan Fasting in Type 1 Diabetes

June 28, 2018 updated by: Dr.Yara Eid, Ain Shams University

Comparison of Two Health Education Modalities for Safe Ramadan Fasting in People With Type 1 Diabetes

Adult Muslims are obliged to start fasting during the month of Ramadan. Fasting entails refraining from all food, drink, tablets and injections(vitamins & fluids) between sunrise and sunset; a period which varies by geographical location and season.

People with type 1 Diabetes are among those who are risky to fast this holy month in the Muslim faith and thus are exempted from fasting. Yet many patients fast in spite of medical advice and religious exemption and for those patients, healthcare professionals should provide the utmost care and continuous diabetes education.

Different diabetes education modalities exist like DSME (Diabetes self-management education with proven efficacy. One modality is the Diabetes Conversation Map which delivers diabetes education interactively through a series of maps that address different issues in diabetes management and includes a specially designed Ramadan map.

In this study, two modalities of Diabetes focused Ramadan education will be compared regarding aiding patients to fast Ramadan safely. One modality will be Diabetes conversation maps and the other the International Diabetes Federation Education modules.

Study Overview

Detailed Description

Adult Muslims are obliged to start fasting during the month of Ramadan. Fasting entails refraining from all food, drink, tablets and injections(vitamins & fluids) between sunrise and sunset; a period which varies by geographical location and season. Although exempt, many diabetics refuse to take this concession as they feel psychologically & spiritually inclined to fast along with other Muslims.

Fasting at Ramadan carries a very high risk for people with T1DM. This risk is particularly exacerbated in poorly controlled patients and those with limited access to medical care, hypoglycemic unawareness, unstable glycemic control, or recurrent hospitalizations.

Structured education interventions have been endorsed by the National Institute for Health and Clinical Excellence as important in empowering patients to improve their jour¬ney with diabetes. In a large observational study, patients who fasted during Ramadan without attending a structured education session had a fourfold increase in hypoglycae¬mic events, whereas those who attended an education pro¬gramme focusing on Ramadan had a significant decrease in hypoglycemic events.

Conversation Map aims to help people with diabetes experience a healthier Ramadan. The interactive Map covers a number of topics including understanding the risks and complications of fasting and the importance of creating a diabetes management plan during this time.

Study Type

Interventional

Enrollment (Actual)

53

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11591
        • Ain-Shams University-Faculty of Medicine- Ain-Shams University Hospitals -Internal Medicine Department -Endocrinology and Metabolism Unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 35 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients are intending to fast .
  2. Duration of diabetes is more than 5 years .
  3. Insulin regimen is basal-bolus .

Exclusion Criteria:

  1. Acute complications as major events of hypoglycemia or DKA during the last 3 months before Ramadan .
  2. Pregnancy .
  3. Previous stroke, MI, or unstable angina .

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: IDF modules
Diabetes educations using IDF Arabic translated modules
Patients in this arm will receive Pre-Ramadan education using IDF module for 4 weeks prior to Ramadan fasting
Experimental: Conversational Maps
Diabetes Educations using Ramadan fasting conversational maps (Arabic maps)
Patients in this arm will receive Pre-Ramadan Education using Ramadan Fasting Diabetes conversation map for 4 weeks prior to Ramadan fasting

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hypoglycemia
Time Frame: Detected through Self monitoring of blood glucose during 4 weeks of Ramadan fasting
Rate of attacks of hypoglycemia during Ramadan
Detected through Self monitoring of blood glucose during 4 weeks of Ramadan fasting

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insulin Dose Adjustment
Time Frame: During 4 weeks of Ramadan fasting
percent reduction or increase in basal and bolus insulin dose during month of Ramadan
During 4 weeks of Ramadan fasting
Body Weight Change
Time Frame: Measurement of body weight prior month of Ramadan and after the month of Ramadan
Increase or decrease of body weight at the end of Ramadan month fasting
Measurement of body weight prior month of Ramadan and after the month of Ramadan
Number of successful fasting days
Time Frame: During 4 weeks of Ramadan fasting
Number of days completed fasting per patient
During 4 weeks of Ramadan fasting

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yara M Eid, MD, Ain-Shams University -Faculty of Medicine
  • Study Chair: Manal A AbuShady, MD, Ain-Shams University -Faculty of Medicine
  • Study Director: Mona M AbdelSalam, MD, Ain-Shams University -Faculty of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 7, 2018

Primary Completion (Actual)

June 28, 2018

Study Completion (Actual)

June 28, 2018

Study Registration Dates

First Submitted

April 10, 2018

First Submitted That Met QC Criteria

April 16, 2018

First Posted (Actual)

April 18, 2018

Study Record Updates

Last Update Posted (Actual)

June 29, 2018

Last Update Submitted That Met QC Criteria

June 28, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 1

Clinical Trials on IDF modules

Subscribe